Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Soy Vitamin D Calcium Softgel (marketed under the brand name Dimeilan) is an oral dietary supplement developed by Anshi Pharmaceutical. It is formulated as a softgel capsule containing calcium carbonate, cholecalciferol (vitamin D3), and soy isoflavones. The combination is designed to support bone health and increase bone density, particularly in postmenopausal women. Calcium carbonate provides elemental calcium for bone mineralization, cholecalciferol enhances calcium absorption via the vitamin D receptor (VDR), and soy isoflavones act as phytoestrogens (selective estrogen receptor modulators) to help mitigate bone resorption associated with estrogen decline during menopause.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Soy Vitamin D Calcium Softgel.